RLMDRelmada Therapeutics, Inc.Mar 19, 2026Q4 2025
Read transcript →Relmada Therapeutics, Inc. (RLMD)
NASDAQ·Healthcare·Biotechnology
$7.10
+0.85%
Mkt Cap $528.74M
RLMDRelmada Therapeutics, Inc.Mar 19, 2026RLMDRelmada Therapeutics, Inc.Nov 13, 2025Q3 2025
Read transcript →RLMDRelmada Therapeutics, Inc.Aug 8, 2025Q2 2025
Read transcript →RLMDRelmada Therapeutics, Inc.May 12, 2025Q1 2025
Read transcript →RLMDRelmada Therapeutics, Inc.Mar 27, 2025Q4 2024
Read transcript →RLMDRelmada Therapeutics, Inc.Nov 10, 2024Q3 2024
Read transcript →RLMDRelmada Therapeutics, Inc.Aug 9, 2024Q2 2024
Read transcript →RLMDRelmada Therapeutics, Inc.May 8, 2024Q1 2024
Read transcript →RLMDRelmada Therapeutics, Inc.Mar 19, 2024Q4 2023
Read transcript →RLMDRelmada Therapeutics, Inc.Nov 9, 2023Q3 2023
Read transcript →RLMDRelmada Therapeutics, Inc.Aug 8, 2023Q2 2023
Read transcript →RLMDRelmada Therapeutics, Inc.May 12, 2023Q1 2023
Read transcript →RLMDRelmada Therapeutics, Inc.Mar 23, 2023Q4 2022
Read transcript →RLMDRelmada Therapeutics, Inc.Nov 12, 2022Q3 2022
Read transcript →RLMDRelmada Therapeutics, Inc.Aug 14, 2022Q2 2022
Read transcript →RLMDRelmada Therapeutics, Inc.May 8, 2022Q1 2022
Read transcript →RLMDRelmada Therapeutics, Inc.Mar 23, 2022Q4 2021
Read transcript →RLMDRelmada Therapeutics, Inc.Nov 11, 2021Q3 2021
Read transcript →RLMDRelmada Therapeutics, Inc.Aug 10, 2021Q2 2021
Read transcript →RLMDRelmada Therapeutics, Inc.May 12, 2021Q1 2021
Read transcript →RLMDRelmada Therapeutics, Inc.Mar 24, 2021Q4 2020
Read transcript →